Heterocyclylalkylamines as muscarinic receptor antagonists
US6667301B2 · kind B2 · utility
4Cited by
13References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2001 |
| Grant date | Dec 23, 2003 |
| Priority date | — |
| Expiry date | May 27, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds which are generally muscarinic M2/M3 receptor antagonists and which are represented by Formula I: wherein X, Y, and Z are O, S or NR5, and the other substituents are as defined in the specification; and prodrugs, individual isomers, racemic or non-racemic mixtures of isomers, and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds and methods for their use as therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.